Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin76.5%-0.6pp77.2%-0.5pp77.7%-0.6pp78.3%0.0pp78.3%+0.3pp
Operating margin21.1%-2.9pp24%-3.3pp27.3%-1.4pp28.7%+2.5pp26.2%-0.5pp
Net margin16.2%-2.1pp18.3%-4.2pp22.5%-0.9pp23.4%+2.9pp20.5%+0.1pp
Returns
Return on equity17.9%-2.9pp20.8%-5.2pp25.9%-1.7pp27.6%+2.9pp24.7%-1.1pp
Return on invested capital31.2%-14.4pp45.6%-2.7pp48.3%+4.3pp44%+5.5pp38.5%-0.7pp
Efficiency
Asset turnover0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×
Liquidity
Current ratio3.6×0.0×3.6×-0.2×3.8×-0.1×3.8×+0.2×3.7×+0.4×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×
Net debt / EBITDA-2×+0.5×-2.5×-0.6×-1.9×-0.4×-1.5×-0.1×-1.4×-0.2×
Per Share
Book value per share$15.49+4.2%$14.86+4.5%$14.22+7.5%$13.23+7.5%$12.31+8.1%
Valuation
Market capitalization$1.62B-24.8%$2.16B+35.9%$1.59B-13.9%$1.84B-3.3%$1.9B-3.0%
Price / earnings11.1×-2.5×13.6×+5.0×8.5×-1.6×10.2×-2.3×12.5×-1.0×
Price / sales1.8×-0.7×2.5×+0.6×1.9×-0.5×2.4×-0.2×2.6×-0.2×
Price / book1.8×-0.7×2.5×+0.6×1.9×-0.5×2.4×-0.3×2.6×-0.3×
EV / EBITDA5.6×-1.2×6.8×+2.3×4.4×-1.5×-1.3×7.3×-0.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Harmony Biosciences Holdings, Inc.'s profit margins?
Harmony Biosciences Holdings, Inc. (HRMY) runs a 76.5% gross margin and a 21.1% operating margin, with a 16.2% net margin.
Where do Harmony Biosciences Holdings, Inc.'s ratios come from?
Every ratio is computed from Harmony Biosciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.